SEC Form 4 · accession 0000856982-18-000080
MERIT MEDICAL SYSTEMS INC · MMSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald Frost
Officer — Chief Operating Officer
Period of report
Nov 7, 2018
Accepted (ET)
Nov 9, 2018 · 6:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000856982
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Nov 7, 2018 | M | 5,257 | $13.14 | A | 5,257 | D | |
| Common Stock, No Par ValueF2 | Nov 7, 2018 | S | 5,257 | $61.308 | D | 0 | D | |
| Common Stock, No Par ValueF1 | holding | — | — | — | 16,239 | I | By 401(k) plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified stock options (right to buy)F3 | $13.14 | Nov 7, 2018 | M | 5,257 | D | Jul 31, 2014 | Jul 31, 2020 | Common Stock | 5,257 | 4,743 | D |
| Non-qualified stock options (right to buy)F4 | $12.06 | holding | — | — | — | Oct 4, 2015 | Oct 4, 2021 | Common Stock | 25,000 | 25,000 | D |
| Non-qualified stock options (right to buy)F5 | $17.27 | holding | — | — | — | Feb 13, 2016 | Feb 13, 2022 | Common Stock | 20,000 | 20,000 | D |
| Non-qualified stock options (right to buy)F6 | $16.05 | holding | — | — | — | Jan 28, 2017 | Jan 28, 2023 | Common Stock | 20,000 | 20,000 | D |
| Non-qualified stock options (right to buy)F7 | $28.20 | holding | — | — | — | Apr 14, 2018 | Apr 14, 2024 | Common Stock | 50,000 | 50,000 | D |
| Non-qualified stock options (right to buy)F8 | $44.80 | holding | — | — | — | Mar 2, 2019 | Mar 2, 2025 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1Represents plan holdings as of 11/07/2017.
- F2The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.30 to $61.35, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F3Became exercisable in equal annual installments of 20% commencing 07/31/2014.
- F4Become exercisable in equal annual installments of 20% commencing 10/04/2015.
- F5Become exercisable in equal annual installments of 20% commencing 02/13/2016.
- F6Become exercisable in equal annual installments of 20% commencing 01/28/2017.
- F7Become exercisable in equal annual installments of 20% commencing 04/14/2018.
- F8Becomes exercisable in equal annual installments of 20% commencing 03/02/2019.